K4R2-Nal2-S1

General Information


DRACP ID  DRACP01589

Peptide Name   K4R2-Nal2-S1

Sequence  KKKKRRXXKKWRKWLAKK

Sequence Length  18

UniProt ID  Not available

PubChem CID  Not available

Origin  Cationic antimicrobial peptides (CAMPs)

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
PC-9 Lung adenocarcinoma Carcinoma When the peptide concentrations was 35μM, the Cell survival rate(%) was 0% MTT assay 3 h Patent
PC-9G Lung adenocarcinoma Carcinoma When the peptide concentrations was 25μM, the Cell survival rate(%) was 0% MTT assay 3 h Patent
A549 Lung adenocarcinoma Carcinoma When the peptide concentrations was 50μM, the Cell survival rate(%) was 0% MTT assay 3 h Patent
OECM-1 Gingival squamous cell carcinoma; Squamous cell carcinoma of the oral cavity Carcinoma When the peptide concentrations was 50μM, the Cell survival rate(%) was 0% MTT assay 3 h Patent
SAS Tongue squamous cell carcinoma; Squamous cell carcinoma of the oral tongue Carcinoma When the peptide concentrations was 50μM, the Cell survival rate(%) was 70% MTT assay 3 h Patent
PC-9 Lung adenocarcinoma Carcinoma When the peptide concentrations was 50μM, the Cell survival rate(%) was 1% MTT assay 3 h Patent
PC-9 Lung adenocarcinoma Carcinoma When the peptide concentrations was 50μM, the Cell survival rate(%) was 0% MTT assay 12 h Patent
PC-9G Lung adenocarcinoma Carcinoma When the peptide concentrations was 50μM, the Cell survival rate(%) was 0% MTT assay 12 h Patent
A549 Lung adenocarcinoma Carcinoma When the peptide concentrations was 50μM, the Cell survival rate(%) was 0% MTT assay 12 h Patent
OECM-1 Gingival squamous cell carcinoma; Squamous cell carcinoma of the oral cavity Carcinoma When the peptide concentrations was 50μM, the Cell survival rate(%) was 0% MTT assay 12 h Patent
SAS Tongue squamous cell carcinoma; Squamous cell carcinoma of the oral tongue Carcinoma When the peptide concentrations was 50μM, the Cell survival rate(%) was 72% MTT assay 12 h Patent
PC-9 Lung adenocarcinoma Carcinoma When the peptide concentrations was 50μM, the Cell survival rate(%) was 72% MTT assay 12 h Patent
PC-9 Lung adenocarcinoma Carcinoma When the peptide concentrations was 50μM, the Cell survival rate(%) was 10% MTT assay 24 h Patent
PC-9G Lung adenocarcinoma Carcinoma When the peptide concentrations was 50μM, the Cell survival rate(%) was 0% MTT assay 24 h Patent
A549 Lung adenocarcinoma Carcinoma When the peptide concentrations was 50μM, the Cell survival rate(%) was 1% MTT assay 24 h Patent
OECM-1 Gingival squamous cell carcinoma; Squamous cell carcinoma of the oral cavity Carcinoma When the peptide concentrations was 50μM, the Cell survival rate(%) was 0% MTT assay 24 h Patent
SAS Tongue squamous cell carcinoma; Squamous cell carcinoma of the oral tongue Carcinoma When the peptide concentrations was 50μM, the Cell survival rate(%) was 2% MTT assay 24 h Patent
PC-9 Lung adenocarcinoma Carcinoma When the peptide concentrations was 50μM, the Cell survival rate(%) was 10% MTT assay 24 h Patent

Hemolytic Activity  human red blood cells: no hemolytic activity of the peptide was found even at 802 μM

Normal (non-cancerous) Cytotoxicity  human fibroblast: When the peptide concentrations was 100μM, the Cell survival rate(%) was 31%

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Acetylization

C-terminal Modification  Amidation

Other Modification  X=Nal=β-naphthylalanine

Chiral  L



Physicochemical Information


Formula  C103H178N36O15

Absent amino acids  CDEFGHIMNPQSTVY

Common amino acids  K

Mass  268417

Pl  12.85

Basic residues  12

Acidic residues  0

Hydrophobic residues  4

Net charge  12

Boman Index  -8332

Hydrophobicity  -248.89

Aliphatic Index  27.22

Half Life 
  /

Extinction Coefficient cystines  11000

Absorbance 280nm  647.06

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US10093699B2

Patent Title  Peptides with antimicrobial, anticancer and/or wound-healing promoting activities, pharmaceutical compositions containing the same, and use of the peptides with antimicrobial, anticancer and/or wound-healing promoting activities

Other Iinformation  Granted Patent; Family: 4s / 4ex; Family Jurisdictions: TW, US; Legal Status: Active; Application No: 201615130709; Filed: Apr 15, 2016; Published: Oct 9, 2018; Earliest Priority: Nov 5, 2015; Granted: Oct 9, 2018

Other Published ID  TW201716428A  TWI619731B  US10093699B2 




DRACP is developed by Dr.Zheng's team.